InterMune is a company headquartered in the United States.
InterMune is a biopharmaceutical company focused on developing therapies for rare and serious diseases, particularly in the area of pulmonary and fibrotic conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.